What is leflunomide, and what is it used for?
Leflunomide is a prescription medicine used to treat rheumatoid arthritis and psoriatic arthritis. It helps control inflammation and can slow joint damage over time.
How does leflunomide work?
Leflunomide reduces immune activity. By dampening the immune processes that drive these autoimmune diseases, it can reduce pain, swelling, and stiffness and help prevent further disease progression.
How is leflunomide usually taken?
The exact dose depends on the condition and your prescribing clinician’s plan. Some regimens start with a loading dose and then continue with a maintenance dose; others may start directly on a maintenance dose.
What side effects do people commonly report?
Commonly reported side effects can include gastrointestinal upset (such as diarrhea or nausea), headache, and elevated liver enzymes. Because liver-related risk can occur, clinicians typically monitor blood tests during treatment.
Why is liver monitoring important with leflunomide?
Leflunomide can affect liver function, so treatment often involves periodic bloodwork to check liver enzymes and ensure the drug is being tolerated safely.
What precautions matter most (pregnancy, infections, and drug interactions)?
Leflunomide has major safety concerns for pregnancy risk, so it is generally avoided when pregnancy is possible unless specific pregnancy-risk management steps are followed. It can also increase susceptibility to infections, and it may interact with other medicines—so medication reviews are important before and during treatment.
Is there a “washout” or stop-and-clear approach?
If leflunomide needs to be stopped for reasons such as pregnancy planning or significant side effects, clinicians may use a washout approach to remove the drug more quickly from the body. The specific protocol depends on patient circumstances.
Where can I find more detailed prescribing/patient information?
For up-to-date information tied to the drug’s patent and market history, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/